Mentor implant business continues despite FDA warning
This article was originally published in Clinica
Mentor, which produces silicone gel and saline breast implants, has come to an agreement with the FDA to bring procedures and controls at its Texas factory in line with Good Manufacturing Practices.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.